Outcome base rates
What's normal — PI grant rate, infringement rate, revocation rate, settlement rate. Honest denominators using motion type.
Patentee win rate
Share of merits decisions where the patentee prevailed — infringement cases finding infringement, revocation cases upholding the patent. Settled, withdrawn, and procedural-only outcomes excluded from the denominator.
43%patentees prevail on the merits
7 merits decisions; 15 inconclusive cases excluded (small sample)
3 won · 4 lost · ↓ 80.0pp vs. prior 12 months
Win rate by year
Patentee win rate by year of first decision.
- 2023: 100% (1/1)
- 2024: 100% (1/1)
- 2025: 20% (1/5)
Win rate by division
Top divisions by merits-decision volume.
- Nordic-Baltic RD100%(n=1)
- Milan LD67%(n=3)
- Munich LD0%(n=1)
- The Hague LD0%(n=1)
- Mannheim LD0%(n=1)
When patentees lose, why?
Of 4 losses…
50%
50%
Patent invalidated — 2 (50%)No infringement found — 2 (50%)
PI grant rate
60%
3 granted · 2 denied · 5 total decisions
PI grant rate (conservative)
60%
Granted / total PI decisions (incl. interim, withdrawn)
Infringement rate
67%
4 infringed · 2 not infringed
Revocation rate
—
Settlement / withdrawal rate
Settled / withdrawn / dismissed as a share of all non-pending outcomes.
29% 5 / 17
Outcomes by category (detailed)
Stacked breakdown using sharper outcome enums — revocation cases split into revoked_full / revoked_partial / maintained_as_*, etc.
Settlement timing
When settled or withdrawn cases actually closed — relative to procedural milestones.
By technology sector
Top sectors by case count (filter scope applied).
By case category
How outcome rates differ across the six L2 buckets.
- Infringement34
- Revocation19
- Other9
- Provisional measures9
By division
PI grant rate · infringement rate · revocation rate per division (within scope).
- Milan LD44 casesPI grant rate: 100%Infringement rate: 100%Revocation rate: —
- Munich LD8 casesPI grant rate: —Infringement rate: —Revocation rate: —
- Nordic-Baltic RD4 casesPI grant rate: —Infringement rate: 100%Revocation rate: —
- Hamburg LD4 casesPI grant rate: 0%Infringement rate: —Revocation rate: —
- Paris LD4 casesPI grant rate: —Infringement rate: —Revocation rate: —
- Mannheim LD2 casesPI grant rate: —Infringement rate: 0%Revocation rate: —
- The Hague LD2 casesPI grant rate: —Infringement rate: 0%Revocation rate: —
- Dusseldorf LD2 casesPI grant rate: —Infringement rate: —Revocation rate: —
- Copenhagen LD1 casesPI grant rate: —Infringement rate: —Revocation rate: —
Recent decisions
Most recent decisions in scope.
- 2026-02-13UPC_CFI_770/2024Milan LDProcedural onlyThe Milan Local Division issued a post-interim-conference order in Pirelli v. Sichuan Yuanxing Rubber, resolving preliminary objections (with SYR withdrawing a service objection) and addressing admissibility of photographs and product samples from the earlier seizure.
- 2026-01-28UPC_CFI_727/2024Milan LDProcedural onlyThe Milan Local Division issued a post-interim-conference order in Agathon AG v. Intercom s.r.l. and KNARR Vertriebs GmbH, setting out rulings on admissibility of technical drawings filed by the claimant and the handling of conditional auxiliary requests per R. 30.1 RoP.
- 2026-01-08UPC_CFI_377/2025Milan LDProcedural onlyThe Milan Local Division partially granted Primetals Technologies' application for an order to produce evidence under Art. 59 UPCA / R. 190 RoP, requiring Danieli to disclose documents relating to alleged infringement of EP 2 624 977 in steel coiling installations supplied to Hoa Phat Group in Vietnam.
- 2025-12-12UPC_CFI_146/2024Munich LDProcedural onlyThe Munich Local Division issued a rectification order under Rule 353 RoP correcting factual errors in a prior decision in the Sanofi v. Stada/Dr Reddy/Zentiva proceedings, including corrections regarding marketing authorisation holders and expert witness attribution.
- 2025-12-12UPC_CFI_146/2024Munich LDRevokedThe Munich Local Division found patent EP 2 493 466 (relating to cabazitaxel pharmaceutical formulations) invalid for lack of inventive step in infringement proceedings brought by Sanofi against STADA, Dr. Reddy's and Zentiva entities, dismissing the infringement claims.
- 2025-11-19UPC_CFI_802/2024Milan LDInfringedThe Milan Local Division issued a default judgment against the defendants (Gastroteam Abbe AB and Marciuliano Attrezzature) for infringement of Morello Forni's patent rights, ordering an injunction and information disclosure regarding the 'Pizza Former' machine, as defendants failed to participate in proceedings.
- 2025-11-18UPC_CFI_187/2024The Hague LDNot infringedThe Hague Local Division decided in proceedings on infringement and counterclaim for revocation concerning Advanced Cell Diagnostics' RNAscope technology patents (EP 1 910 572 and EP 2 500 439) against Molecular Instruments; the decision addressed novelty, inventive step, and infringement of in situ hybridisation method claims.
- 2025-10-27UPC_CFI_178/2024Milan LDRevokedThe Milan Local Division revoked EP 2 726 230 B1 (mesh production method and device) in its entirety following the defendants' counterclaim, dismissed the application to amend the patent, and dismissed the infringement action; claimant Progress Maschinen bore the majority of costs.